Bedding manufacturer and retailer Sleep Number (NASDAQ:SNBR) beat Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 7.8% year on year to $347.4 million. Its non-GAAP loss of $1.95 per ...
Bicara Therapeutics (NASDAQ:BCAX) is developing tumor-targeting bifunctional antibodies, with its lead candidate ficerasfusp alfa designed to address both EGFR and TGF-beta biology in cancer, company ...
Get all latest & breaking news on Closing High. Watch videos, top stories and articles on Closing High at moneycontrol.com.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results